4-Chloro-7H-pyrrolo[2,3-d]pyrimidine (3680-69-1)
Specifications
CAS:
3680-69-1
End Use:
Tofacitinib
M.F.:
C6H4ClN3
M.W.:
153.57
Assay:
98%
Shelf Life:
2 Years
Package:
25kg/drum
Highlight:
Tofacitinib intermediate pyrimidine bases
,Tofacitinib intermediate CAS: 3680-69-1
,Tofacitinib intermediate
Introduction
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine is an important intermediate in organic synthesis. In the synthesis of Tofacitinib, it is used as intermediate.
Product Name: | 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine |
CAS No.: | 3680-69-1 |
Assay: | 98% |
End Use: | Tofacitinib |
Molecular Formula: | C6H4ClN3 |
Molecular Weight: | 153.57 |
Shelf Life: | 2 Years |
Package: | 25kg/drum |
Related Products
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (477600-74-1)
CAS: 477600-74-1; Tofacitinib manufacturer; Tofacitinib intermediate; Rhematoid Arthritis
Tofacitinib Citrate (540737-29-9)
CAS: 540737-29-9; tofacitinib manufacturer; tofacitinib vitiligo; alopecia tofacitinib
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride (1062580-52-2)
CAS: 1062580-52-2; Tofacitinib manufacturer; Tofacitinib intermediate; Rhematoid Arthritis
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (923036-30-0)
CAS: 923036-30-0; Tofacitinib manufacturer; Tofacitinib intermediate; Rhematoid Arthritis
Image | Part # | Description | |
---|---|---|---|
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (477600-74-1) |
CAS: 477600-74-1; Tofacitinib manufacturer; Tofacitinib intermediate; Rhematoid Arthritis
|
||
Tofacitinib Citrate (540737-29-9) |
CAS: 540737-29-9; tofacitinib manufacturer; tofacitinib vitiligo; alopecia tofacitinib
|
||
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride (1062580-52-2) |
CAS: 1062580-52-2; Tofacitinib manufacturer; Tofacitinib intermediate; Rhematoid Arthritis
|
||
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (923036-30-0) |
CAS: 923036-30-0; Tofacitinib manufacturer; Tofacitinib intermediate; Rhematoid Arthritis
|
Send RFQ
Stock:
In Stock
MOQ: